Pouschine Cook Leads Investment in Curexa Pharmacy

Pfizer's Hospital Business Acquires Arixa Pharmaceuticals

October 22, 2020

Pharmaceuticals

Pfizer’s Hospital Business acquired Arixa Pharmaceuticals to advance development of Arixa’s lead oral prodrug ARX-1796, a potential oral beta-lactamase inhibitor + antibiotic combination. Financial terms were not disclosed; Arixa was a virtual, asset-light company based in Palo Alto and was advised by Four Oaks Partners on the transaction.

QHP Capital (NovaQuest PE) Acquires Lexitas Pharma Services

July 7, 2022

Healthcare Services

QHP Capital, the management company for NovaQuest Private Equity, has acquired Lexitas Pharma Services, a Durham-based full-service ophthalmology contract research organization (CRO). The private equity investment is intended to support Lexitas’s continued growth and capability expansion in ophthalmic clinical trial services for biopharmaceutical and medical device clients.

Capitala Group Exits Investment in Optio Rx

November 11, 2020

Healthcare Services

Capitala Group announced it has exited its senior secured debt and minority equity investment in Optio Rx, a national owner and operator of specialty compounding pharmacies. The original investment was made in partnership with Cold Bore Capital and funded Optio Rx's roll-up of specialty pharmacies serving fertility, veterinary, dermatology, hormone replacement and hospice markets.

Audax Private Equity Makes Growth Investment in Pyramid Laboratories, Inc.

April 18, 2023

Pharmaceuticals

Audax Private Equity has made a growth investment in Pyramid Laboratories, Inc., a Costa Mesa, California-based CDMO that provides formulation development, analytical/stability testing, and aseptic fill-finish manufacturing for large-molecule biologics. The capital will support planned facility expansions to increase vial-filling capacity by more than 30% and syringe filling by more than 50%, and to scale Pyramid's clinical and commercial biologics manufacturing and service operations.

Vesey Street Capital Partners Majority Recapitalizes Inceptua Group

January 16, 2024

Healthcare Services

Vesey Street Capital Partners has completed a majority recapitalization of Luxembourg-headquartered Inceptua Group, a global pharmaceutical services provider specializing in clinical trial supplies and early access programs. As part of the transaction, industry veteran Doug Cook will join Inceptua as Executive Chairman to support the company's capability expansion and growth initiatives alongside CEO Stefan Fraenkel and founder Peter Krantz.

Revelation Pharma (Osceola Capital) Acquires Five Compounding Pharmacies

January 27, 2022

Healthcare Services

Revelation Pharma, a PE-backed specialty pharmacy platform sponsored by Osceola Capital, completed add-on acquisitions of five compounding pharmacies: Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, and Convex Pharmacy. The deals expand Revelation's geographic footprint and clinical capabilities across key U.S. regions and will see some locations merged into existing Revelation businesses (e.g., Wise into Pencol; Convex into Everwell).